QUINATIME Drug Patent Profile
✉ Email this page to a colleague
When do Quinatime patents expire, and what generic alternatives are available?
Quinatime is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in QUINATIME is quinidine gluconate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the quinidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quinatime
A generic version of QUINATIME was approved as quinidine gluconate by SUN PHARM INDUSTRIES on February 11th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUINATIME?
- What are the global sales for QUINATIME?
- What is Average Wholesale Price for QUINATIME?
Summary for QUINATIME
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 1,734 |
| DailyMed Link: | QUINATIME at DailyMed |
US Patents and Regulatory Information for QUINATIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | QUINATIME | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 087448-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
